drugset / Trial / NCT06932367

The Efficacy of Dexketoprofen And Methylprednisolone in the Acute Low Back Pain

NCT06932367

Phase 4 Completed 150 enrolled Ali Gur
RandomizedParallel-groupSingle-blindTreatment

Summary

Many methods have been used in to treat low back pain. In this study, we aimed to investigate the efficacy of dexketoprofen alone and in combination with methylprednisolone in the treatment of low back pain in the emergency department using the Visual Analog Scale (VAS) and the Oswestry Disability Index (ODI).This prospective, randomized, single-blind study included 150 patients admitted to the emergency department of a university hospital. Patients with low back pain were divided in to two groups: those receiving intravenous dexketoprofen treatment (Group D) and those receiving dexketoprofen + methylprednisolone treatment (Group DM). The efficacy of the treatments received by the patients was evaluated with the VAS at minutes 0, 15, 30, and 60 and hour 48. Statistical evaluations were also undertaken on the ODI results evaluated at minute 0 and hour 48.

Timeline

Start
2021-08-01
Primary completion
2022-08-01
Completion
2025-01-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexketoprofen Small molecule 50 mg Intravenous
Subject Methylprednisolone Other / unclassified

Indications

No indication recorded.